Urinary Bladder Diseases (DBCOND0035833)

Identifiers

Synonyms
Urinary Bladder Disease / Bladder disorder, unspecified / Unspecified disorder of bladder / Disease of bladder (disorder) / Bladder disorder / Bladder disorder NOS

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05153694
Infectious Complications After Cystectomy: A Prospective Observational StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05250908
INTIBIA Pivotal StudyNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT02307487
Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patientstreatment2completed
NCT02254915
SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study INo drug interventionstreatment3withdrawn
NCT01638000
A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.treatment3completed
NCT01930799
Bladder Management in Patients With Multiple Sclerosis: Optimizing Practice PatternsNo drug interventionshealth_services_research4completed
NCT04442724
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapyNo drug interventionstreatmentNot Availablerecruiting
NCT03845725
Falls and Balance of Patients With Parkinson's Disease With Urinary DisturbanceNo drug interventionsNot AvailableNot Availablecompleted
NCT06237920
Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimabtreatment2recruiting
NCT01340027
A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladdertreatment2completed
NCT00384891
Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder CancerNo drug interventionstreatment3terminated
NCT01908829
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)treatment3completed
NCT01060254
A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Paintreatment2terminated
NCT04922047
Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01)treatment1 / 2unknown_status
NCT03245242
Pediatric Urology Recovery After Surgery Endeavor (PURSUE)No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04914442
Eosinophilic Cystitis Mimicking Urothelial NeoplasiaNo drug interventionsNot AvailableNot Availablecompleted
NCT04161716
Study Evaluating the Ability of a NIRS Module to Detect a Urodynamic Variation in Humans (DETTECH)No drug interventionsdevice_feasibilityNot Availablecompleted
NCT03081858
Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancertreatment1 / 2completed
NCT05643963
The COOKER-BLADDER TrialNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT02320773
A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical PracticeNot AvailableNot Availablecompleted
NCT02891460
Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC PatientsNo drug interventionstreatmentNot Availablecompleted
NCT02386072
A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)Not AvailableNot Availablecompleted
NCT02401542
Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinomatreatment1 / 2terminated
NCT01613586
A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)No drug interventionstreatment2completed
NCT03123055
A Study of B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinomatreatment1 / 2terminated